GGrantIndex
← Leaderboards

Shahid Umar

University Of Texas Medical Br Galveston

$5,946,599
Attributed
$8,608,504
Total exposure
5
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY200822
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$8,608,504 · 5

By mechanism

R01$8,457,504 · 4
R03$151,000 · 1

Top collaborators

Most similar at University Of Texas Medical Br Galveston

Same institution · by research overlap

Others in their field

Top investigators on “Epithelial Cells

Research focus

Epithelial CellsSignal TransductionMediatingBaseInflammationPreventResponseIn VitroColon CarcinomaCellsMutantMalignant NeoplasmsPathway InteractionsDietHyperplasiaPreventionBiological MarkersIntestinesProgramsEventExhibitsButyratesBacteriaArea

Grant awards (22)

Single Immunoglobulin Interleukin-1 Related Receptor and necrotizing enterocolitis in premature infants$501,668
R01 · FY2022 · DK
Single Immunoglobulin Interleukin-1 Related Receptor and necrotizing enterocolitis in premature infants$514,112
R01 · FY2021 · DK
Single Immunoglobulin Interleukin-1 Related Receptor and necrotizing enterocolitis in premature infants$515,604
R01 · FY2020 · DK
Single Immunoglobulin Interleukin-1 Related Receptor and necrotizing enterocolitis in premature infants$533,316
R01 · FY2019 · DK
Epigenetics and Infection-induced EMT of Colonic Crypts - Target for Chemoprevention$373,069
R01 · FY2019 · CA · contact PI
Bitter Melon Component and Colon Cancer Prevention$544,710
R01 · FY2018 · CA
Single Immunoglobulin Interleukin-1 Related Receptor and necrotizing enterocolitis in premature infants$535,560
R01 · FY2018 · DK
Epigenetics and Infection-induced EMT of Colonic Crypts - Target for Chemoprevention$384,608
R01 · FY2018 · CA · contact PI
Bitter Melon Component and Colon Cancer Prevention$544,710
R01 · FY2017 · CA
Epigenetics and Infection-induced EMT of Colonic Crypts - Target for Chemoprevention$384,608
R01 · FY2017 · CA · contact PI
Bitter Melon Component and Colon Cancer Prevention$544,710
R01 · FY2016 · CA
Epigenetics and Infection-induced EMT of Colonic Crypts - Target for Chemoprevention$380,222
R01 · FY2016 · CA · contact PI
Bitter Melon Component and Colon Cancer Prevention$544,710
R01 · FY2015 · CA
Epigenetics and Infection-induced EMT of Colonic Crypts - Target for Chemoprevention$392,972
R01 · FY2015 · CA · contact PI
Bitter Melon Component and Colon Cancer Prevention$544,710
R01 · FY2014 · CA
Beta-Catenin/NF-kB in Hyperplasia/Neoplasia of Colonic Crypts: Chemoprevention$200,466
R01 · FY2011 · CA · contact PI
Beta-Catenin/NF-kB in Hyperplasia/Neoplasia of Colonic Crypts: Chemoprevention$95,225
R01 · FY2011 · CA · contact PI
Beta-Catenin/NF-kB in Hyperplasia/Neoplasia of Colonic Crypts: Chemoprevention$304,812
R01 · FY2010 · CA · contact PI
Beta-Catenin/NF-kB in Hyperplasia/Neoplasia of Colonic Crypts: Chemoprevention$304,788
R01 · FY2009 · CA · contact PI
Beta-Catenin/NF-kB in Hyperplasia/Neoplasia of Colonic Crypts: Chemoprevention$312,924
R01 · FY2008 · CA · contact PI
beta-Catenin/NF-kappaBeta and Colon Cancer$75,500
R03 · FY2004 · CA
beta-Catenin/NF-kappaBeta and Colon Cancer$75,500
R03 · FY2003 · CA